Huang Yimei, Miller Brett, Doemer Anthony, Babij Dan, Kumar Sanath, Frontera Rene, Nurushev Teamour, Chetty Indrin J, Aref Ibrahim
Department of Radiation Oncology, Henry Ford Health System, Detroit, MI 48202, USA.
Brachytherapy. 2013 May-Jun;12(3):260-6. doi: 10.1016/j.brachy.2012.08.008. Epub 2013 Feb 28.
To present a clinical procedure that readjusts catheters to its planned positions based on pretreatment computed tomography (CT) for patients undergoing high-dose-rate (HDR) prostate brachytherapy, and evaluate the magnitude and dosimetric impact of the adjustments.
Patients received a pretreatment verification CT (vCT) before each fraction. The vCT dataset was imported to the treatment-planning system and fused to the planning CT (pCT) by rigid-body registration based on the implanted fiducials within the prostate. Catheter positions in the vCT were then compared with catheter positions in the pCT in a reconstructed plane through each catheter. Any catheter with difference in penetration larger than 3 mm was manually adjusted by a radiation oncologist before treatment. To evaluate treatment quality, the patient's plan was applied to the vCT off-line and dose delivered to prostate and normal structures were compared with their planned value.
Forty-four fractions of 13 consecutive patients were treated using this method. Thirty-nine fractions had at least one catheter adjusted before treatment. A total of 651 catheters were assessed, and 194 catheters (30%) were adjusted by an average amount of 5.8 ± 1.9 mm. In eight fractions the prostate D90 would have decreased by more than 10% from the planned value (with a maximum of 32%) if the catheter displacements were not rectified. After the adjustment, the maximum deviation of D90 was 10.6%. The improvement in D90 is 24% per 1 cm of time-averaged adjustment.
Interfraction catheter motion occurs without any particular pattern. Using pretreatment CTs and restoring each catheter to its planned position ensures that the delivered treatment closely matches the treatment plan and therefore enhances the overall quality of the HDR treatment. The procedure can be readily implemented in any clinical setting.
介绍一种针对接受高剂量率(HDR)前列腺近距离放疗的患者,基于治疗前计算机断层扫描(CT)将导管重新调整至计划位置的临床程序,并评估调整的幅度及其剂量学影响。
患者在每次分次治疗前接受一次治疗前验证CT(vCT)。将vCT数据集导入治疗计划系统,并通过基于前列腺内植入的基准标记进行刚体配准,与计划CT(pCT)融合。然后在通过每个导管的重建平面中,将vCT中的导管位置与pCT中的导管位置进行比较。任何穿透差异大于3 mm的导管在治疗前由放射肿瘤学家手动调整。为了评估治疗质量,将患者的计划离线应用于vCT,并将前列腺和正常结构所接受的剂量与其计划值进行比较。
连续13例患者共进行了44次分次治疗。39次分次治疗前至少有一根导管进行了调整。总共评估了651根导管,其中194根导管(30%)进行了调整,平均调整量为5.8±1.9 mm。在8次分次治疗中,如果不纠正导管移位,前列腺D90将比计划值降低超过10%(最大降低32%)。调整后,D90的最大偏差为10.6%。每平均调整1 cm,D90的改善率为24%。
分次治疗期间导管运动会无特定规律地发生。利用治疗前CT并将每根导管恢复到其计划位置,可确保所给予的治疗与治疗计划紧密匹配,从而提高HDR治疗的整体质量。该程序可在任何临床环境中轻松实施。